| pubmed-article:16387397 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16387397 | lifeskim:mentions | umls-concept:C0038925 | lld:lifeskim |
| pubmed-article:16387397 | lifeskim:mentions | umls-concept:C0039487 | lld:lifeskim |
| pubmed-article:16387397 | lifeskim:mentions | umls-concept:C0442043 | lld:lifeskim |
| pubmed-article:16387397 | lifeskim:mentions | umls-concept:C0017436 | lld:lifeskim |
| pubmed-article:16387397 | lifeskim:mentions | umls-concept:C0524865 | lld:lifeskim |
| pubmed-article:16387397 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:16387397 | lifeskim:mentions | umls-concept:C0243067 | lld:lifeskim |
| pubmed-article:16387397 | lifeskim:mentions | umls-concept:C0282815 | lld:lifeskim |
| pubmed-article:16387397 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:16387397 | pubmed:dateCreated | 2006-11-6 | lld:pubmed |
| pubmed-article:16387397 | pubmed:abstractText | The temporalis muscle flap is a useful flap for the reconstruction of oral ablative defects. A complication of its use that was overlooked was the crater-like defect created when the muscle is stripped from its attachment on the temporal fossa. The cold-cure acrylic we use is Palacos R-40 with Gentamicin (Heraeus Kulzer GmbH). This material is radio-opaque, rapidly setting and contains gentamicin. We present a total of 41 cases over an 11-year period (1994-2005). We have a 97.6% (n = 40) success rate. Infection developed in only one case, which leads to the removal of the acrylic implant. The use of Palacos R-40 with Gentamicin is easy to use, it can be custom-moulded to fit and fill the defect any of shape and size. It has minimal complications and high success rate with acceptable results to the patients. | lld:pubmed |
| pubmed-article:16387397 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16387397 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16387397 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16387397 | pubmed:citationSubset | D | lld:pubmed |
| pubmed-article:16387397 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16387397 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16387397 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16387397 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16387397 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16387397 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16387397 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16387397 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:16387397 | pubmed:issn | 0266-4356 | lld:pubmed |
| pubmed-article:16387397 | pubmed:author | pubmed-author:WrightSS | lld:pubmed |
| pubmed-article:16387397 | pubmed:author | pubmed-author:WhearN MNM | lld:pubmed |
| pubmed-article:16387397 | pubmed:author | pubmed-author:GrewN RNR | lld:pubmed |
| pubmed-article:16387397 | pubmed:author | pubmed-author:BekirogluFF | lld:pubmed |
| pubmed-article:16387397 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16387397 | pubmed:volume | 44 | lld:pubmed |
| pubmed-article:16387397 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16387397 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16387397 | pubmed:pagination | 531-3 | lld:pubmed |
| pubmed-article:16387397 | pubmed:dateRevised | 2008-2-6 | lld:pubmed |
| pubmed-article:16387397 | pubmed:meshHeading | pubmed-meshheading:16387397... | lld:pubmed |
| pubmed-article:16387397 | pubmed:meshHeading | pubmed-meshheading:16387397... | lld:pubmed |
| pubmed-article:16387397 | pubmed:meshHeading | pubmed-meshheading:16387397... | lld:pubmed |
| pubmed-article:16387397 | pubmed:meshHeading | pubmed-meshheading:16387397... | lld:pubmed |
| pubmed-article:16387397 | pubmed:meshHeading | pubmed-meshheading:16387397... | lld:pubmed |
| pubmed-article:16387397 | pubmed:meshHeading | pubmed-meshheading:16387397... | lld:pubmed |
| pubmed-article:16387397 | pubmed:meshHeading | pubmed-meshheading:16387397... | lld:pubmed |
| pubmed-article:16387397 | pubmed:meshHeading | pubmed-meshheading:16387397... | lld:pubmed |
| pubmed-article:16387397 | pubmed:meshHeading | pubmed-meshheading:16387397... | lld:pubmed |
| pubmed-article:16387397 | pubmed:meshHeading | pubmed-meshheading:16387397... | lld:pubmed |
| pubmed-article:16387397 | pubmed:meshHeading | pubmed-meshheading:16387397... | lld:pubmed |
| pubmed-article:16387397 | pubmed:meshHeading | pubmed-meshheading:16387397... | lld:pubmed |
| pubmed-article:16387397 | pubmed:meshHeading | pubmed-meshheading:16387397... | lld:pubmed |
| pubmed-article:16387397 | pubmed:meshHeading | pubmed-meshheading:16387397... | lld:pubmed |
| pubmed-article:16387397 | pubmed:meshHeading | pubmed-meshheading:16387397... | lld:pubmed |
| pubmed-article:16387397 | pubmed:meshHeading | pubmed-meshheading:16387397... | lld:pubmed |
| pubmed-article:16387397 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16387397 | pubmed:articleTitle | Use of Palacos R-40 with gentamicin to reconstruct temporal defects after maxillofacial reconstructions with temporalis flaps. | lld:pubmed |
| pubmed-article:16387397 | pubmed:affiliation | Department of Oral & Maxillofacial Surgery, New Cross Hospital, Wolverhampton WV10 0QP, United Kingdom. addenbrookes@hotmail.com | lld:pubmed |
| pubmed-article:16387397 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16387397 | lld:pubmed |
